Trimb acquires established European OTC products

On 28 June Trimb Healthcare AB completed the acquisition of a portfolio of well-established European OTC products from Cilag GmbH International and Janssen Pharmaceutica NV (collectively, “J&J”). The portfolio includes products such as Pevaryl®, Fungoral®, Gyno-Pevaryl® and Epi-Pevaryl®, and is based on the active substance econazole nitrate and ketoconazole, which treat fungal infections of the skin.


Trimb Healthcare (“Trimb”) has completed the acquisition of BioClin BV (“BioClin”), a leading intimate healthcare company based in Delft, Netherlands.


Trimb Healthcare AB (“Trimb”) has entered into a definitive agreement with CCS Healthcare Nordic AB (“CCS”) to acquire their portfolio of skin care products in Sweden, Norway and the UK (“CCS Skinc


You’ve been the CEO since June; tell us about it.

I assumed the position of CEO at Trimb in the middle of June, just as we completed the acquisition of Pevaryl and Fungoral from J&J.